ARTICLE | Company News
Kinexis, Merck deal
October 25, 2004 7:00 AM UTC
Kinexis determined that prokineticin proteins modify the circadian rhythm in animal models, triggering an undisclosed milestone payment from MRK. Under a 2003 deal, the companies are working together ...